A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe

Annals of Oncology

Volumn 24, Issue 6, 2013, Pages 1667-1674

  Bertuccio, P ^a,b   Bosetti, C ^a   Levi, F ^c   Decarli, A ^b,d   Negri, E ^a   La Vecchia, C ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cancer; Cholangiocarcinoma; Hepatocellular carcinoma; Intrahepatic; Liver; Mortality

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRIA; BILE DUCT CARCINOMA; CANCER MORTALITY; COMPARATIVE STUDY; CZECH REPUBLIC; EUROPE; FEMALE; FINLAND; FRANCE; GERMANY; HUMAN; ITALY; JAPAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PORTUGAL; PRIORITY JOURNAL; SEX DIFFERENCE; SEX RATIO; SPAIN; SWEDEN; UNITED KINGDOM;

CANCER; CHOLANGIOCARCINOMA, HEPATOCELLULAR CARCINOMA; INTRAHEPATIC; LIVER; MORTALITY;

AUSTRALIA; CHOLANGIOCARCINOMA; EUROPE; EUROPEAN UNION; FEMALE; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL RATE; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 84876723794     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds652     Document Type: Article

References (39)

1. La Vecchia C, Lucchini F, Franceschi S et al. Trends in mortality from primary liver cancer in Europe. Eur J Cancer 2000; 36: 909-915.
2. Bosetti C, Levi F, Boffetta P et al. Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology 2008; 48: 137-145.
3. Center MM, Jemal A. International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev 2011; 20: 2362-2368.
4. McGlynn KA, London WT. The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis 2011; 15: 223-243.
5. von Hahn T, Ciesek S, Wegener G et al. Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany. Scand J Gastroenterol 2011; 46: 1092-1098.
6. Shaib YH, Davila JA, McGlynn K et al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 2004; 40: 472-477.
7. El-Serag HB, Engels EA, Landgren O et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology 2009; 49: 116-123.
8. Shaib YH, El-Serag HB, Davila JA et al. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 2005; 128: 620-626.
9. Shaib YH, El-Serag HB, Nooka AK et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 2007; 102: 1016-1021.
10. Welzel TM, Graubard BI, El-Serag HB et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case- control study. Clin Gastroenterol Hepatol 2007; 5: 1221-1228.
11. Nordenstedt H, Mattsson F, El-Serag H et al. Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma. Br J Cancer 2012; 106: 1011-1015.
12. World Health Organization Statistical Information System. WHO mortality database http://www.who.int/whosis/mort/download/en/index.html (November 2011, last accessed).
13. World Health Organization. International Classification of Disease: 9th Revision. Geneva: World Health Organization 1977.
14. World Health Organization. International Statistical Classification of Disease and related Health Problems: 10th revision. Geneva: World Health Organization 1992.
15. Doll R, Smith PG. Comparison between registries: age-standardized rates. Vol. IV. IARC Sci Publ No. 42. In Waterhouse JAH, Muir CS, Shanmugaratnam K et al. (eds), Cancer Incidence in Five Continents. Lyon: IARC 1982; 671-675.
16. National Cancer Institute. Joinpoint Regression Program, version 3.5.2. http://srab.cancer.gov/joinpoint/ (October 2011, Last accessed).
17. Kim HJ, Fay MP, Feuer EJ et al. Permutation tests for joinpoint regression with applications to cancer rates. (Erratum in: Stat Med 2001;20: 655). Stat Med 2000; 19: 335-351.
18. Clegg LX, Hankey BF, Tiwari R et al. Estimating average annual per cent change in trend analysis. Stat Med 2009; 28: 3670-3682.
19. Percy C, Ries LG, Van Holten VD. The accuracy of liver cancer as the underlying cause of death on death certificates. Public Health Rep 1990; 105: 361-367.
20. Duberg AS, Hultcrantz R. Misleading figures on trends in mortality from hepatocellular carcinoma in Europe. Hepatology 2009; 49: 336; author reply 336-337.
21. Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol 2002; 17: 1049-1055.
22. de Martel C, Plummer M, Franceschi S. Cholangiocarcinoma: descriptive epidemiology and risk factors. Gastroenterol Clin Biol 2010; 34: 173-180.
23. Khan SA, Emadossadaty S, Ladep NG et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?. J Hepatol 2012; 56: 848-854.
24. Welzel TM, McGlynn KA, Hsing AW et al. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 2006; 98: 873-875.
25. Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 2010; 42(Suppl 3): S206-S214.
26. Raza SA, Clifford GM, Franceschi S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer 2007; 96: 1127-1134.
27. Trichopoulos D, Bamia C, Lagiou P et al. Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst 2011; 103: 1686-1695.
28. Randi G, Altieri A, Gallus S et al. History of cirrhosis and risk of digestive tract neoplasms. Ann Oncol 2005; 16: 1551-1555.
29. La Vecchia C, Negri E, Cavalieri d'Oro L et al. Liver cirrhosis and the risk of primary liver cancer. Eur J Cancer Prev 1998; 7: 315-320.
30. La Vecchia C, Negri E, Decarli A et al. Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 1997; 73: 204-207.
31. Bosetti C, Rosato V, Polesel J et al. Diabetes mellitus and cancer risk in a network of case-control studies. Nutr Cancer 2012; 64: 643-651.
32. Bosetti C, Levi F, Lucchini F et al. Worldwide mortality from cirrhosis: an update to 2002. J Hepatol 2007; 46: 827-839.
33. Zatonski WA, Sulkowska U, Manczuk M et al. Liver cirrhosis mortality in Europe, with special attention to Central and Eastern Europe. Eur Addict Res 2010; 16: 193-201.
34. Chuang SC, La Vecchia C, Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett 2009; 286: 9-14.
35. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365: 1118-1127.
36. Chow WH, McLaughlin JK, Menck HR et al. Risk factors for extrahepatic bile duct cancers: Los Angeles County, California (USA). Cancer Causes Control 1994; 5: 267-272.
37. Levi F, Lucchini F, Negri E et al. The recent decline in gallbladder cancer mortality in Europe. Eur J Cancer Prev 2003; 12: 265-267.
38. Randi G, Malvezzi M, Levi F et al. Epidemiology of biliary tract cancers: an update. Ann Oncol 2009; 20: 146-159.
39. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 2006; 118: 1591-1602.